BRIEF published on 11/12/2024 at 13:05, 1 year 3 months ago Yunu nomme Patrick McNamara pour accélérer sa croissance Yunu Développement Des Affaires Sciences De La Vie Patrick McNamara Imagerie D'essais Cliniques
BRIEF published on 11/12/2024 at 13:05, 1 year 3 months ago Yunu Appoints Patrick McNamara to Accelerate Growth Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
PRESS RELEASE published on 11/12/2024 at 13:00, 1 year 3 months ago Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara Yunu appoints Patrick McNamara as Senior VP of Business Development to drive growth initiatives in life sciences sector with expertise in clinical trial imaging workflow and data management solutions Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
BRIEF published on 09/12/2024 at 13:05, 1 year 5 months ago Yunu étend l'utilisation gratuite de la plateforme du centre de cancérologie pour tous les essais cliniques du groupe d'oncologie pédiatrique Yunu Recherche Clinique Technologie D'imagerie Essais Cliniques Du COG Cancer Pédiatrique
BRIEF published on 09/12/2024 at 13:05, 1 year 5 months ago Yunu Extends Free Cancer Center Use of Platform for All Children's Oncology Group Clinical Trials Clinical Research Imaging Technology Yunu COG Clinical Trials Pediatric Cancer
PRESS RELEASE published on 09/12/2024 at 13:00, 1 year 5 months ago Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials Yunu extends free platform use for Children's Oncology Group (COG) trials nationwide, providing world-class imaging capabilities and transforming pediatric cancer care Clinical Trials Yunu Imaging Workflow Pediatric Cancer Children's Oncology Group
BRIEF published on 07/23/2024 at 13:05, 1 year 6 months ago Taux d'erreur d'imagerie de 50 % dans les essais cliniques discutés par des panélistes d'experts de 5 centres de cancérologie désignés par le NCI Essais Cliniques Recherche Médicale Oncologie Erreurs D'imagerie Plateforme Yunu
BRIEF published on 07/23/2024 at 13:05, 1 year 6 months ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Clinical Trials Oncology Medical Research Imaging Errors Yunu Platform
PRESS RELEASE published on 07/23/2024 at 13:00, 1 year 6 months ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Panel at AACI-CRI symposium highlights concerning imaging accuracy crisis in clinical trials. Yunu's platform addresses issues, leading to significant workflow efficiencies Clinical Trials Yunu Imaging Accuracy Workflow Efficiencies AACI-CRI Symposium
BRIEF published on 05/08/2024 at 13:05, 1 year 9 months ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
Published on 02/20/2026 at 18:30, 16 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 1 minute ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 16 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 38 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 46 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 10 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
